Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 22, 2026

Intel Reports Fourth-Quarter and Full-Year 2025 Financial Results

View original at finance.yahoo.com
Intel Reports Fourth-Quarter and Full-Year 2025 Financial Results News Summary Fourth-quarter revenue was $13.7 billion, down 4% year-over-year (YoY)…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Intel exceeded Q4 expectations across revenue, gross margin, and EPS even while navigating industry-wide supply shortages

    80% confidence
  • Strong customer demand exists for Intel 18A

    80% confidence
  • Our conviction in the essential role of CPUs in the AI era continues to grow

    80% confidence
  • Demand fundamentals across Intel's core markets remain healthy

    80% confidence
  • Intel is the only company with R&D, design, and HVM of leading-edge logic semiconductors at leading nodes in USA

    80% confidence
  • x86 is the world's most widely deployed high-performance compute architecture

    80% confidence
  • Rapid AI adoption is reinforcing x86 importance

    80% confidence
  • Intel delivered a solid finish to the year and made progress on journey to build a new Intel

    80% confidence
  • Intel expects available supply to be at its lowest level in Q1 before improving in Q2 and beyond

    80% confidence
  • Intel 18A is the most advanced process technology developed and manufactured in the United States

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com